RNS Number : 6860B
Sareum Holdings PLC
02 November 2009
|
(AIM: SAR)
|
2 November 2009
|
SAREUM HOLDINGS PLC
("Sareum" or the "Company")
Sareum to Present at BIO-Europe 2009
Sareum (AIM: SAR), the specialist cancer drug discovery business, is pleased to announce that Dr Tim Mitchell, CEO, will present Sareum's cancer drug discovery pipeline at BIO-Europe 2009 later today.
BIO-Europe, being held this year in Vienna, Austria, is Europe's largest biotechnology partnering event. Dr Mitchell's presentation is part of the UK Showcase, an International Seminar introduced by UK Trade & Investment.
|
Sareum Holdings plc
|
|
|
Tim Mitchell
|
01223 497 700
|
|
|
|
|
Merchant John East Securities Limited
|
|
Simon Clements/Bidhi Bhoma
|
020 7628 2200
|
|
|
|
|
Hybridan LLP
|
|
|
Claire Noyce/Stephen Austin
|
020 3159 5085
|
Notes for editors:
About Sareum Holdings plc
Sareum is a drug discovery company, headquartered in Cambridge UK, that is focused on producing targeted small molecule therapeutics to address unmet medical needs, primarily in cancer.
Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.
Sareum Holdings plc joined the AIM market of the London Stock Exchange in October 2004, trading under the symbol SAR. For further information, please visit www.sareum.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALBLFXKBBXFBF